158|10000|Public
50|$|It {{can also}} {{precipitate}} autoimmune disease through {{the suppression of}} <b>suppressor</b> <b>T</b> <b>cell</b> populations and/or the emergence of autoreactive B-cells.|$|E
5000|$|The {{resolution}} of the I-J paradox involves a process of mutual selection (or [...] "co-selection") of suppressor T cells and helper T cells, meaning that (a) those suppressor T cells are selected that have V regions with complementarity to as many helper T cells as possible, and (b) helper T cells are selected {{not only on the}} basis of their V regions having some affinity for MHC class II, but also on the basis of the V regions having some affinity for the selected <b>suppressor</b> <b>T</b> <b>cell</b> V regions. The helper T cells and suppressor T cells that are co-selected are then a mutually stabilizing construct, and for a given mouse genome, more than one such mutually stabilizing set can exist. This {{resolution of}} the I-J paradox leads to some testable predictions.|$|E
50|$|Studies {{of human}} {{subjects}} {{with a history}} of leishmania infection suggest that modulation of CD8+ suppressor T cells is, at least partly, mediated by cytokines. Leishmania specific CD4+ helper T cells predominate in adults with strong protective immunity (skin-test positive with no history of clinical infection). When added to autologous leishmania infected macrophages these T cells cause parasite death and secretion of large amounts of interferon-gamma and lymphotoxin. CD8+ T suppressor cells predominate in patients with no protective immunity (visceral leishmaniasis patients). When added to autologous peripheral blood mononuclear cells isolated after successful treatment, these T cells inhibit interferon-gamma secretion and proliferation and increase interleukin-6 and interleukin-10 secretion. A soluble factor(s) generated by antigen or phytohemagglutinin stimulation of leishmania-specific CD4+ helper T cells from skin-test positive adults killed CD8+ T cells but not CD4+ helper T cells when added to culture media. Soluble factors generated by antigen stimulation of peripheral blood mononuclear cells from skin-test positive adults prevented CD8+ <b>suppressor</b> <b>T</b> <b>cell</b> mediated increases in interleukin-10 secretion. These findings suggest that antigen stimulation of CD4+ helper T cells results in production of cytokines that kill or down regulate CD8+ T suppressor cells. Once the leishmania infection has been eliminated and leishmania antigens are gone, CD8+ T suppressor cells down-regulate CD4+ T helper cells. Isolation of cytokines that inhibit and kill CD8+ T suppressor cells might be useful in treating diseases that involve immune suppression such as leishmaniasis, AIDS, and certain cancers.|$|E
40|$|The role of {{mononuclear}} phagocyte system (MPS) in {{the induction}} of <b>suppressor</b> <b>T</b> <b>cells</b> which depress the delayed footpad reaction to sheep erythrocytes (SRBC) was studied in mice in which MPS was blocked or stimulated. Colloidal carbon and diethylstilbestrol {{were used for}} blockade and stimulation respectively. Adoptive transfer of <b>suppressor</b> <b>T</b> <b>cells</b> was achieved by spleen cells of mice immunized intraperitoneally with varying doses of SRBC. In nontreated mice, 1 x 10 (9) SRBC were required to induce <b>suppressor</b> <b>T</b> <b>cells,</b> while 6 x 10 (8) could not induce the <b>suppressor</b> <b>T</b> <b>cells.</b> In MPS-blocked mice, however, even 6 x 10 (8) SRBC could induce the <b>suppressor</b> <b>T</b> <b>cells.</b> On the other hand, 3 x 10 (10) SRBC were required for the induction of <b>suppressor</b> <b>T</b> <b>cells</b> in MPS-stimulated mice. These {{results suggest that the}} activity of macrophages as scavenger cells modulates the subsequent induction of <b>suppressor</b> <b>T</b> <b>cells</b> after immunization with high doses of SRBC...|$|R
40|$|Cellular events {{mediated}} by antigen-specific soluble factor extracted from carrier-primed <b>suppressor</b> <b>T</b> <b>cells</b> (TsF) in the suppressive interaction was studied. Keyhole limpet hemocyanin (KLH) -specific TsF directly acts on KLH-primed, I-J positive, nylon-wool-adherent <b>T</b> <b>cells</b> {{that have an}} acceptor site for TsF. The nylon-wool-adherent <b>T</b> <b>cells,</b> after accepting TsF {{in the presence of}} specific antigen, generate new <b>suppressor</b> <b>T</b> <b>cells</b> acting as an actual effector cell type. Antigen- specificity and syngeneity at I-J between TsF and acceptor <b>T</b> <b>cells</b> are both required for the induction of new <b>suppressor</b> <b>T</b> <b>cells.</b> Newly induced <b>suppressor</b> <b>T</b> <b>cells,</b> however, suppress both syngeneic and allogeneic responses in an antigen-nonspecific fashion...|$|R
40|$|Murine {{antibody}} {{responses to}} insulins {{are controlled by}} MHC-linked Ir genes. Although mice of the H- 2 b haplotype do not make antibody in response to pork insulin, we demonstrate in this communication that immunization with pork insulin stimulates radioresistant, Lyt- 1 + 2 - helper <b>T</b> <b>cells</b> {{that are capable of}} stimulating secondary antibody responses to pork insulin in vitro, but that this activity is masked by radiosensitive, Lyt- 1 - 2 +, I-J+ <b>suppressor</b> <b>T</b> <b>cells.</b> The <b>suppressor</b> <b>T</b> <b>cells,</b> present after immunization with pork insulin but not beef insulin, suppress the secondary response to pork but not beef insulin. The amino acid sequences of pork and beef insulins differ only at the A- chain loop; thus, pork insulin-specific <b>suppressor</b> <b>T</b> <b>cells</b> appear to recognize the A-chain loop determinant of pork insulin. The amino acid sequences of mouse and pork insulin are identical in the A-chain loop, which suggests that these <b>suppressor</b> <b>T</b> <b>cells</b> may be self-reactive. If this interpretation is correct, these <b>suppressor</b> <b>T</b> <b>cells</b> could be involved in the maintenance of self-tolerance to insulin. Nevertheless, these data clearly demonstrate that genetically determined nonresponsiveness in H- 2 b mice is conferred by activation of dominant, insulin-specific <b>suppressor</b> <b>T</b> <b>cells</b> (<b>Ts),</b> rather than by a defect in the stimulation of insulin-specific helper <b>T</b> <b>cells</b> (Th) ...|$|R
40|$|Hyperimmunization of BALB/c mice with concanavalin A-stimulated blasts {{from the}} Ig allotype-congenic strain, C. B 20, {{results in the}} {{production}} of antibodies reactive with T cells in an allotype-restricted manner. Spleen cells from these hyperimmune BALB/c mice were used to generate a panel of hybridomas that secrete monoclonal antibodies, reactive, in an allotype-restricted manner, exclusively with T cells subpopulations, and in particular, reactive with <b>suppressor</b> <b>T</b> <b>cell</b> hybridomas and their secreted soluble factors. Two functional classes of antibodies were identified: those that react with single polypeptide-chain <b>suppressor</b> <b>T</b> <b>cell</b> factors (TsF 1) and the <b>suppressor</b> <b>T</b> <b>cell</b> hybridomas that produce such factors, and those that react with two polypeptide-chain <b>suppressor</b> <b>T</b> <b>cell</b> factors (TsF 2) and their corresponding <b>suppressor</b> <b>T</b> <b>cell</b> hybridomas. These two classes of antibody were used to isolate molecules from the membranes of the respective <b>suppressor</b> <b>T</b> <b>cell</b> hybrids that are functionally and structurally related to the secreted <b>suppressor</b> <b>T</b> <b>cell</b> factors, suggesting a receptor function for these molecules...|$|E
40|$|Familial Mediterranean fever (FMF) is {{a genetic}} {{disorder}} with an obscure aetiology. In attempts {{to investigate a}} possible immunoregulatory imbalance involved in this disease we tested 24 FMF patients for <b>suppressor</b> <b>T</b> <b>cell</b> activity and for chemotaxis of mononuclear cells. The <b>suppressor</b> <b>T</b> <b>cell</b> activity and chemotaxis were decreased in untreated FMF patients as compared to colchicine treated patients or normal controls. Amyloid FMF patients manifested significantly increased chemotactic activity, while the <b>suppressor</b> <b>T</b> <b>cell</b> activity was normal. This finding may extend our knowledge concerning the immune mechanism involved in FMF...|$|E
40|$|A simple {{procedure}} {{to enrich the}} antigen (keyhole limpet hemocyanin, KLH) -specific <b>suppressor</b> <b>T</b> <b>cell</b> was described. The <b>suppressor</b> <b>T</b> <b>cell</b> from KLH) -immunized mice specifically bound to the KLH-coated Sephadex G- 200 column at 37 degrees C, and was eluted from the column by cold (0 - 4 degrees C) medium. The helper T cell did not bind to the column under the identical condition. The <b>suppressor</b> <b>T</b> <b>cell</b> thus obtained had 100 times as potent suppressor activity as the original spleen cells in in vivo and in vitro secondary antibody responses against a hapten coupled to KLH. This procedure also enriched the cells bearing I-J determinants and Lyt- 2, 3 alloantigens, allowing us to study the phenotypic expressions on the <b>suppressor</b> <b>T</b> <b>cell</b> by direct serological procedures {{as well as by}} the use of the fluorescence activated cell sorter. Parallel functional and serological analyses indicated that the antigen- specific <b>suppressor</b> <b>T</b> <b>cell</b> belongs to a population of I-J+, Lyt- 2 +, 3 + and Fc R- T cells...|$|E
40|$|<b>Suppressor</b> <b>T</b> <b>cells</b> {{acting on}} the efferent phase (Ts-eff) of dinitrofluorobenzene-contact {{sensitivity}} (DNFB-CS) were induced in BALB/c mice by injection of dinitrobenzenesulphonate (DNBSO 3) and subsequent painting (sensitization) with DNFB. Ts-eff cells released a suppressor factor, antigen and strain specific, which was active in vivo in sensitized recipients. Administration of DNBSO 3 alone generated <b>suppressor</b> <b>T</b> <b>cells,</b> which acted only on the afferent phase (Ts-aff). <b>Suppressor</b> <b>T</b> <b>cells</b> could not be detected in mice painted with DNFB and desensitized later by injection of DNBSO 3...|$|R
40|$|The {{results of}} this study confirm results {{published}} by others by showing that sublethal whole-body irradiation of mice bearing immunogenic tumors can result in complete tumor regression. The results show, in addition, that irradiation-induced tumor regression can be prevented by infusion, after irradiation, of Ly- 1 +, 2 -,L 3 <b>T</b> 4 + <b>suppressor</b> <b>T</b> <b>cells</b> from the spleens of donors bearing an established tumor, but not by infusion of normal spleen cells. This evidence, plus the demonstration that irradiation fails to cause regression of tumors growing in immunocompetent mice, is consistent with the hypothesis that irradiation-induced regression is immunologically mediated, and that it depends on the ability of irradiation to preferentially eliminate <b>suppressor</b> <b>T</b> <b>cells.</b> By using passive transfer assays to measure the production of effector <b>T</b> <b>cells</b> and <b>suppressor</b> <b>T</b> <b>cells</b> against time of tumor growth, it was shown that irradiation of tumor-bearing mice on day 5 of tumor growth resulted in a failure to generate <b>suppressor</b> <b>T</b> <b>cells</b> on the one hand, and in a sustained production, effector <b>T</b> <b>cells</b> on the other. In other words, irradiation prevented the concomitant antitumor immune response from being downregulated by <b>suppressor</b> <b>T</b> <b>cells.</b> However, giving radiation on day 1 of tumor growth, in contrast to giving it 3 - 6 d later, caused immunodepression and enhancement of tumor growth. This is in keeping with published evidence showing that, whereas resting effector <b>T</b> <b>cells</b> are highly radiosensitive, antigen- activated effector <b>T</b> <b>cells</b> are relatively radioresistant. It is suggested that the radioresistance of activated effector <b>T</b> <b>cells,</b> coupled with the radiosensitivity of activated <b>suppressor</b> <b>T</b> <b>cells,</b> is the reason for the selectivity of ionizing radiation for <b>suppressor</b> <b>T</b> <b>cells</b> and why a tumor needs to be palpable to undergo regression in response to radiation therapy...|$|R
40|$|Background: CD 8 + <b>suppressor</b> <b>T</b> <b>cells</b> exert antigen-specific {{suppression}} of the expression of hypersensitivity by activated <b>T</b> <b>cells.</b> Therefore, CD 8 + <b>suppressor</b> <b>T</b> <b>cells</b> serve a major regulatory role for the control of active immunity. Accordingly, the number and/or activity of CD 8 + <b>suppressor</b> <b>T</b> <b>cells</b> should be influenced by an immune response to the antigen. To test this hypothesis we used an adoptive transfer assay that measures the {{suppression of}} the expression of delayed-type hypersensitivity (DTH) by CD 8 + <b>suppressor</b> <b>T</b> <b>cells</b> to quantify the antigen-specific suppression of DTH by these <b>suppressor</b> <b>T</b> <b>cells.</b> Methods: <b>Suppressor</b> <b>T</b> <b>cells</b> were induced in the spleens of mice by the injection of antigen into the anterior chamber of an eye. Following this injection, the mice were immunized by the same antigen injected into the anterior chamber. Spleen cells recovered from these mice (AC-SPL cells) were titrated in an adoptive transfer assay to determine the number of AC-SPL cells required to effect a 50 % reduction of antigen-induced swelling (Sw 50) in the footpad of immunized mice challenged by antigen. Results: Suppression of the expression of DTH is proportional to the number of AC-SPL cells injected into the site challenged by antigen. The number of AC-SPL cells required for a 50 % reduction in DTH-induced swelling is reduced by injecting a cell population enriched for CD 8 + AC-SPL cells. Immunizing the mice receiving intracameral antigen to the sam...|$|R
40|$|Recent {{evidence}} suggests {{the presence of}} a <b>suppressor</b> <b>T</b> <b>cell</b> defect in systemic lupus erythematosus. We confirm the presence of such a defect and find a strong quantitative correlation between the loss of <b>suppressor</b> <b>T</b> <b>cell</b> function and the activity of SLE as measured by {{the presence of a}}ntibodies to native DNA. In addition, the serum of patients with active SLE contains a soluble factor which when incubated with normal peripheral blood lymphocytes induces a <b>suppressor</b> <b>T</b> <b>cell</b> defect. These data are consistent with the suppressor cell defect being involved in the propagation and possible the pathogenesis of SLE, and suggests a positive feedback mechanism whereby a suppressor cell defect results in autoantibodies including antibody to suppressor cells...|$|E
40|$|<b>Suppressor</b> <b>T</b> <b>cell</b> {{function}} is decreased {{in patients with}} chronic active liver diseases (CALD). To account for the alterations, we examined the effect of sera of patients with various liver diseases on concanavalin A (Con A) induced <b>suppressor</b> <b>T</b> <b>cell</b> activity of normal individuals. The <b>suppressor</b> <b>T</b> <b>cell</b> activity was inhibited by heat-inactivated serum pretreatment in 13 of 27 cases of patients with CALD and in five of 11 cases of patients with acute viral hepatitis, whereas only two sera of 18 patients with other liver diseases affected suppressor cell activity. Using a 125 I-C 1 q-binding test, a significant correlation (P less than 0. 01) was detected between the degree of inhibition {{in the development of}} suppressor T cells and the level of circulating immune complexes in the sera of CALD patients. The blocking effect of patients' sera disappeared when the immune complexes were removed with polyethylene glycol. These data suggest that circulating immune complexes modulate cellular immunity in patients with CALD by influencing the <b>suppressor</b> <b>T</b> <b>cell</b> function...|$|E
40|$|<b>Suppressor</b> <b>T</b> <b>cell</b> {{activity}} {{was measured in}} 18 patients with Crohn's disease and 20 controls, using two different functional assays. The effects of sulphasalazine and its metabolites on in vitro suppressor cell activity were also studied. The activity of a Con A-induced suppressor cell system in patients with Crohn's disease {{did not differ from}} that of controls, suggesting that the previously reported abnormalities are a secondary phenomenon. Furthermore, the activity of a non-induced <b>suppressor</b> <b>T</b> <b>cell</b> system was also normal in these patients. There was no evidence either in vivo or in vitro to suggest that sulphasalazine exerts its beneficial action by an effect on this aspect of immunoregulation...|$|E
40|$|Little {{is known}} about the {{molecular}} basis for activation of <b>suppressor</b> <b>T</b> <b>cells.</b> In this report we describe two macrophage cell lines, BAC 1. 2. SC 8 and its variant progeny B 26, that differ in their ability to activate <b>suppressor</b> <b>T</b> <b>cells.</b> The SC 8 line is derived from a (BALB/c x A. CA) F 1 (H- 2 d/f) mouse and is haploid with respect to I-Ed. It is capable of activating I-Ed-restricted helper <b>T</b> <b>cells</b> as well as poly-(Glu 50 Tyr 50) -specific I-Ed-restricted suppressor cells. The B 26 variant can activate H- 2 d-restricted helper <b>T</b> <b>cells</b> but activates H- 2 k-restricted suppressor cells. The I-Ed molecules of SC 8 and of B 26 have identical amino acid sequences. This suggests that <b>suppressor</b> <b>T</b> <b>cells</b> either recognize posttranslational modifications of the I-E molecule or that there is another accessory molecule that helps determine the major histocompatibility complex restriction in the activation of <b>suppressor</b> <b>T</b> <b>cells...</b>|$|R
40|$|BACKGROUND: CD 8 (+) <b>suppressor</b> <b>T</b> <b>cells</b> exert antigen-specific {{suppression}} of the expression of hypersensitivity by activated <b>T</b> <b>cells.</b> Therefore, CD 8 (+) <b>suppressor</b> <b>T</b> <b>cells</b> serve a major regulatory role for the control of active immunity. Accordingly, the number and/or activity of CD 8 (+) <b>suppressor</b> <b>T</b> <b>cells</b> should be influenced by an immune response to the antigen. To test this hypothesis we used an adoptive transfer assay that measures the {{suppression of}} the expression of delayed-type hypersensitivity (DTH) by CD 8 (+) <b>suppressor</b> <b>T</b> <b>cells</b> to quantify the antigen-specific suppression of DTH by these <b>suppressor</b> <b>T</b> <b>cells.</b> METHODS: <b>Suppressor</b> <b>T</b> <b>cells</b> were induced in the spleens of mice by the injection of antigen into the anterior chamber of an eye. Following this injection, the mice were immunized by the same antigen injected into the anterior chamber. Spleen cells recovered from these mice (AC-SPL cells) were titrated in an adoptive transfer assay to determine the number of AC-SPL cells required to effect a 50 % reduction of antigen-induced swelling (Sw 50) in the footpad of immunized mice challenged by antigen. RESULTS: Suppression of the expression of DTH is proportional to the number of AC-SPL cells injected into the site challenged by antigen. The number of AC-SPL cells required for a 50 % reduction in DTH-induced swelling is reduced by injecting a cell population enriched for CD 8 (+) AC-SPL cells. Immunizing the mice receiving intracameral antigen to the same antigen decreases the RSw 50 of AC-SPL cells required to inhibit the expression of DTH. CONCLUSIONS: The results provide the first quantitative demonstration that the numbers of antigen-specific splenic CD 8 (+) <b>suppressor</b> <b>T</b> <b>cells</b> are specifically amplified by antigen during an immune response...|$|R
25|$|<b>Suppressor</b> <b>T</b> <b>cells</b> {{along with}} Helper <b>T</b> <b>cells</b> can collectively be called Regulatory <b>T</b> <b>cells</b> {{due to their}} {{regulatory}} functions.|$|R
40|$|Prolonged {{administration}} of micromolar amounts of 2 '-deoxyguanosine (dGuo) to lethally irradiated and reconstituted mice {{led to an}} increased incidence of transient homogeneous immunoglobulins (H-Ig) in their sera. Analysis of the heavy and light chain isotype distribution among the H-Ig revealed more of the IgG 2 b and IgG 3 isotypes and less of the IgM isotype and the lambda light chain containing H-Ig in the dGuo-treated group {{as compared to the}} control group. The increased incidence of H-Ig was preceded by a decreased <b>suppressor</b> <b>T</b> <b>cell</b> generation and activation in the dGuo treated group. These data indicate that deficient <b>suppressor</b> <b>T</b> <b>cell</b> activity {{plays an important role in}} the development of transient H-Ig...|$|E
40|$|Delayed {{hypersensitivity}} reaction in mice was commonly enhanced with various anti-cancer agents administered as single or intermittent high doses but not consecutive divided doses. The effect of anti-cancer agents on the delayed {{hypersensitivity reaction}} {{was thought to be}} due to elimination of <b>suppressor</b> <b>T</b> <b>cell</b> activity...|$|E
40|$|The {{effect of}} blood {{transfusion}} on humoral immunity in {{chronic renal failure}} was studied by examining immunoglobulin production in vitro, in patients awaiting renal transplantation. Pokeweed mitogen (PWM) induced IgG plaque formation was normal in non-transfused uraemic patients while both spontaneous and Staphylococcus aureus Cowan I (SAC) induced immunoglobulin production were reduced. Five to ten units of third party blood transfusion reduced PWM-driven B cell differentiation, but {{had no effect on}} SAC-induced plaque formation, while spontaneous production of immunoglobulin was either enhanced or unaffected. As it is known that the response to SAC is less affected by <b>suppressor</b> <b>T</b> <b>cell</b> activity than that to PWM, these differences in the inhibitory effects of blood transfusion on B cell differentiation are further evidence that transfusion may act by increasing <b>suppressor</b> <b>T</b> <b>cell</b> activity...|$|E
40|$|In the {{previous}} papers {{of this series}} (1, 2), it was shown that the antigen-reactive <b>T</b> <b>cells</b> capable of replicating vesicular stomatitis virus (VSV) ] developed in the spleen of mice after the immunization with sheep erythrocytes (SRBC). The time-course {{of the development of}} VSV-replicating <b>T</b> <b>cells</b> did not correlate with that of delayed-type hypersensitivity (DTH), helper <b>T</b> <b>cells,</b> or <b>suppressor</b> <b>T</b> <b>cells</b> found in the nylon wool nonadherent (NAd) population. It was also shown that VSV-replicating <b>T</b> <b>cells</b> derived from the T 1 population (Raft and Cantor, [3]), whereas the major part of helper <b>T</b> <b>cells</b> derived from the T 2 population. Experiments in this paper were undertaken to investigate the function of VSVreplicating <b>T</b> <b>cells</b> in antibody response, taking advantage of the finding that VSVreplicating cells are eliminated by the preinfection procedure (4). Results indicate that VSV-replicating <b>T</b> <b>cells</b> induced by SRBC are nylon wool adherent (Ad) <b>suppressor</b> <b>T</b> <b>cells</b> that develop after the development of helper <b>T</b> <b>cells</b> or nylon wool NAd <b>suppressor</b> <b>T</b> <b>cells.</b> The role of the nylon Ad <b>suppressor</b> <b>T</b> <b>cells</b> in antibody response is discussed in relation to the concept of T 1 -T 2 interaction. Materials and Method...|$|R
40|$|Despite a {{large body}} of {{evidence}} concerning the phenomenon of immune tolerance at the <b>T</b> <b>cell</b> level, the actual mechanism of unresponsiveness is not understood. Experimentally, <b>T</b> <b>cell</b> unresponsiveness can be induced in adults by the intravenous injection of high doses of soluble antigen (1) or of antigen coupled to syngeneic splenocytes (reviewed in references 2 - 6). Two major hypotheses have been proposed (3 - 6) to explain unresponsiveness: regulation by <b>suppressor</b> <b>T</b> <b>cells</b> or direct inactivation of responding <b>T</b> <b>cells</b> by antigen. The suppression model of unresponsiveness states that a complex circuit of interacting <b>suppressor</b> <b>T</b> <b>cells</b> prevent the expression of inducer <b>T</b> <b>cell</b> function. The antigen and MHC specificity of suppression has been shown in most systems to be different from that of inducer <b>T</b> <b>cells,</b> e. g., inducer <b>T</b> <b>cells</b> recognize antigen in association with class 11 MHC (Ia) molecules, while <b>suppressor</b> <b>T</b> <b>cells</b> often recognize antigen in an unrestricted fashion, or in association with 1 -J molecules (2, 7, 8). However, several instances of la-restricted antigen recognition by <b>suppressor</b> <b>T</b> <b>cells</b> have been described (9, 10). As an alternative t...|$|R
40|$|A {{number of}} {{clinical}} and experimental findings suggest {{the involvement of}} <b>suppressor</b> <b>T</b> <b>cells</b> in self-tolerance and autoimmune disease (1 - 3). It is, however, a matter of conjecture whether a defect in <b>suppressor</b> <b>T</b> <b>cells</b> plays a primary role in the pathogenesis of autoimmune disease, or only an incidental one. A definitive experiment would be one in which autoimmune disease is induced by the removal of <b>suppressor</b> <b>T</b> <b>cells</b> from the immune system of an otherwise normal animal, and, further, self-tolerance can be reestablished, and autoimmune disease prevented, by reconstituting such an animal with <b>suppressor</b> <b>T</b> <b>cells.</b> Organ-specific autoimmune disease can be induced in rodents by treatments that deplete a subpopulation of T cells: Neonatal thymectomy of some strains of mice caused autoimmune disease in several endocrine organs (4). Autoimmune thyroiditis developed in adult rats that underwent thymectomy followed by repeated sublethal irradiation (5). Since the appearance of autoimmune disease was clearly prevented by the reconstitution of these animals with <b>T</b> <b>cells</b> from syngeneic normal animals (6, 7), it has been postulated that autoimmune diseas...|$|R
40|$|We have {{previously}} reported that {{two types of}} <b>suppressor</b> <b>T</b> <b>cell</b> factors (TsF) specific for L-glutamic acid 50 -L-tyrosine 50 (GT) or L-glutamic acid 60 -L-alanine 30 -L-tyrosine 10 (GAT) can be distinguished based upon differences {{in their ability to}} suppress responses by allogeneic mice. Injection of GAT or GT induces a <b>suppressor</b> <b>T</b> <b>cell</b> subset that produces an antigen-binding, I-J+, genetically unrestricted, specific suppressor factor (TsF 1). Injection of this factor plus small amounts of antigen induces a second-order <b>suppressor</b> <b>T</b> <b>cell</b> that produces an antigen- binding, I-J+, genetically restricted, specific suppressor factor (TsF 2). In this report, we demonstrate that these two factors are also biochemically distinct. Monoclonal TsF 1 molecules are composed of a single polypeptide chain that bears both the antigen-binding site and I- J determinant, whereas TsF 2 molecules are composed of two disulfide- linked polypeptide chains, one of which is antigen-binding and I-J-, and the other, nonantigen-binding, I-J+. The antigen-binding chain must be added at culture initiation to achieve suppression, but the I-J+ chain can be added as late as day 3 with complete suppression observed. However, isolated chains from TsF 2 -producing hybridomas derived from three different haplotypes were unable to suppress immune responses when chains from heterologous TsF 2 were mixed. Indirect evidence is presented that suggests that this restriction is because the chains fail to interact rather than the inability of the target cells to recognize both chains...|$|E
40|$|Bone marrow {{transplantation}} (BMT) {{is currently}} {{used to treat}} patients with severe haematological disorders. One of its major complications is acute graft versus host disease (aGVHD). In this report we show that, {{during the early stages}} of lymphoid cell repopulation, an excess of <b>suppressor</b> <b>T</b> <b>cell</b> activity and a deficit of helper T cell activity are easily demonstrated by functional studies in healthy BMT recipients. On the contrary, in patients with active signs of aGVHD, a loss of suppressor T cells, as assessed by coculturing recipient T cells with donor B cells in an in vitro pokeweed mitogen (PWM) dependent Ig secreting assay, is detected. The loss of suppressor T cells in these patients is revealed also by the analysis of peripheral blood lymphocytes with the OKT 5 suppressor cytotoxic monoclonal antibody (MoAb) but not with the OKT 8 suppressor cytotoxic MoAb. Our data demonstrate that in several BMT recipients, during active aGVHD, a <b>suppressor</b> <b>T</b> <b>cell</b> deficit can be demonstrated both functionally and phenotypically...|$|E
40|$|Low {{concentrations}} (40 microM) of the {{purine nucleoside}} metabolite 2 'deoxyguanosine (2 'dGuo), {{were shown to}} enhance both phytohaemagglutinin- and concanavalin A-induced T cell transformation. Evidence is presented which indicates that this enhancement {{may be due to}} the inhibition of <b>suppressor</b> <b>T</b> <b>cell</b> function resulting in the promotion of T cell growth factor production. T cell responses were only inhibited at concentrations of 2 'dGuo which were toxic to the lymphocytes...|$|E
40|$|The allotypic {{determinants}} exclusively expressed on <b>suppressor</b> <b>T</b> <b>cells</b> (Tsud) a or inducer of <b>suppressor</b> <b>T</b> <b>cells</b> (Tind d) {{have been}} demonstrated (1, 2) by antisera or monoclonal antibodies that were made by immunizations of an immunoglobulin heavy chain (Igh) allotype congenic pair of mice (i. e., BALB/c anti-C. AL- 20). The genes coding for the <b>T</b> <b>cell</b> allotypic determinants have unambiguously been mapped between the Igh constant region genes (Igh-C) and the prealbumin gene (Pre- 1) on the 12 th chromosome (3). Furthermore, the determinants seem to be present on the antigen receptor on <b>suppressor</b> <b>T</b> <b>cells</b> because the binding of idiotype-specific <b>suppressor</b> <b>T</b> <b>cells</b> to the idiotype-bearing Ig was blocked by the antiserum (1). Therefore, these results suggested that <b>T</b> <b>cell</b> antigen receptors can be encoded by genes linked to the Igh genes. In fact, {{we have been able}} to demonstrate (4) that the antiserum made by immunizations of BALB/c (H- 2 a, Igh- 1 o) mice with <b>T</b> <b>cell</b> blasts from the Igh allotype cogenic mice CB- 20 (H- 2 a, Igh- 1 b) detects the allotypic determinants on the antigenspecific <b>T</b> <b>cell</b> factors, i. e., suppressor (TsF) or augmenting factor (TaF), whic...|$|R
40|$|<b>Suppressor</b> <b>T</b> <b>cells</b> {{have been}} shown to be much more {{radiosensitive}} than other lympho√Ød cells, and we have tried to reduce tumor growth by low-dose irradiation. Syngeneic DBA/ 2 mice received whole-body irradiation (150 rads; 1 rad = 0. 01 J/kg) 6 days after P 815 tumor inoculation. Tumor growth is significantly reduced in mildly irradiated mice. We also attempted to reduce syngeneic tumor growth by raising immunity against <b>suppressor</b> <b>T</b> <b>cells</b> in two different systems. DBA/ 2 mice were immunized against splenic <b>T</b> <b>cells</b> collected after disappearance of cytotoxicity and then injected with P 815 tumor cells. These mice develop a very high primary cytotoxicity against P 815 cells. C 57 BL/ 6 mice were immunized against blastic <b>suppressor</b> <b>T</b> <b>cells,</b> before injection of <b>T</b> 2 tumor <b>cells.</b> Some of these mice reject the tumor and other develop smaller tumors than control mice. These results could be explained by the induction of antiidiotypic activity directed against the immunological receptors of <b>suppressor</b> <b>T</b> lymphocytes, because immunization with blastic <b>suppressor</b> <b>T</b> <b>cells</b> from mice bearing the T 2 tumor does not modify the growth of another tumor, T 10...|$|R
40|$|Neonatal <b>suppressor</b> <b>T</b> <b>cells</b> were {{isolated}} from the thymuses of 10 - to 14 -day old BDF mice infected at birth with mouse thymic virus. Such cells were enriched for suppressive activity directed against antibody formation by adult B cells and represented a relatively homogenous population of outer cortical cells. Their surface antigen phenotype was found to be: Ly 1 +, Ly 2 +, TL+, Thy 1 +, and H- 2 +. The cells were larger and contained more DNA than thymocytes from age-matched controls. These findings identify neonatal <b>suppressor</b> <b>T</b> <b>cells</b> as a unique subpopulation separate from most inducible suppressor cells in the adult mouse. The mechanism of action of neonatal <b>suppressor</b> <b>T</b> <b>cells</b> {{seems to be a}} {{reduction in the number of}} B cells initially triggered by antigen...|$|R
40|$|Immune {{responses}} {{are known to}} be regulated by complicated interactions of T cells with different functional roles. In our previous studies of the cellular mechanism of suppression of antibody response in the keyhole limpet hemocyanin (KLH) 1 system, we have demonstrated that at least three distinct subsets of suppressor T cells are involved in the regulatory T cell interactions (1). 2 These T cell populations involve suppressor T cells that produce antigen-specific <b>suppressor</b> <b>T</b> <b>cell</b> factor (TsF), suppressor T cells bearing a receptor for TsF (acceptor-suppressor T cells), and effector-suppressor T cells. The KLH-specific TsF with antigen-binding moiety and I-J determinants, which is composed of two polypeptide chains, is obtained from Lyt- 2 + suppresor T cells. In the initial step of the suppressor pathways, the KLH-specific <b>suppressor</b> <b>T</b> <b>cell</b> factor (KLH-TsF) acts on and activates Lyt-l+, 2 + acceptor-suppressor T cells. In the second step, the activated acceptor-suppressor T cells generate new effector-suppressor T cells that directly suppress the responses mounted by B cells and helper T cells. Therefore, the antigen-specific TsF seems not to be an effector-suppresso...|$|E
40|$|The {{rearrangement}} and transcription of the {{antigen receptor}} alpha, beta and gamma genes were investigated in murine antigen-specific <b>suppressor</b> <b>T</b> <b>cell</b> lines, to establish whether the <b>suppressor</b> <b>T</b> <b>cell</b> subset expresses the same antigen receptor transcripts previously found in helper and cytotoxic T lymphocytes. The genomic {{organization of the}} alpha, beta and gamma chain loci was investigated using probes representative of the entire gene or fragments from variable, joining and constant regions. The present results show that in functional suppressor T cells the three antigen receptor genes are all rearranged. The beta gene is expressed in all the tested cell lines, while {{the expression of the}} alpha and gamma genes is variable. In one cell line (LH 8) alpha and gamma genes are not efficiently transcribed; in the other cell line (LA 41) the gamma mRNA is found in amounts similar to beta mRNA, whereas the alpha gene is expressed at low levels. These data suggest that in suppressor T cells no direct correlation exists between the expression of alpha, beta and gamma antigen receptor genes and the effector function...|$|E
40|$|Regulation of immune {{responses}} involves {{complex interaction}} between {{a number of}} T cell sets (1, 2). These interactions often require a genetic homology between the T cells involved for the functional activity to be manifest. Two gene polymorphisms control genetic restrictions between cells of <b>suppressor</b> <b>T</b> <b>cell</b> circuits. The first major restricting element of <b>suppressor</b> <b>T</b> <b>cell</b> interactions concerns antigens of the major histocompatibility gene complex (MHC). 1 The other restricting element involves genes encoded in or linked to the variable region (V) of the Igh gene loci. The {{question of how the}} Igh-V-related gene products involved in T suppressor cell interactions relate to the antigen specificity of the cellular interactions is not well known, although a number of investigators have suggested an idiotype-antiidiotype-like interaction similar to the one originally proposed by Jerne (3). Investigations into the nature of genetically restricted T cell interactions have been greatly facilitated by the use of cell-free products that replace the activity of functional T cell sets. One such product is an antigen-specific, T cell-derive...|$|E
40|$|This {{study shows}} that {{surgical}} removal of the meth A fibrosarcoma from its semisyngeneic host fails to result in postexcision immunity to growth of a tumor implant unless the host already has acquired a mechanism of concomitant immunity to growth of an implant. Therefore, tumor excision does not cause immunity to be generated but preserves a mechanism of concomitant immunity that already exists and which otherwise would eventually undergo down-regulation {{under the influence of}} <b>suppressor</b> <b>T</b> <b>cells.</b> Removal of the tumor after it has grown large enough to cause the T cell-mediated suppression of concomitant immunity does not result in the reemergence of immunity. Instead, the host remains unable to generate concomitant immunity to a second tumor {{for a long period of}} time and retains, for at least 31 d, <b>suppressor</b> <b>T</b> <b>cells</b> able to passively transfer suppression to appropriate recipients. Like the <b>suppressor</b> <b>T</b> <b>cells</b> responsible for active suppression of concomitant immunity, the <b>suppressor</b> <b>T</b> <b>cells</b> responsible for "memory" suppression are of the Ly- 1 + 2 - phenotype. The results indicate that progressive tumor growth results in a state of immunological tolerance of tumor-specific, transplantation antigens that can persist in the apparent absence of tumor antigens...|$|R
40|$|Although alloantigen-specific <b>suppressor</b> <b>T</b> <b>cells</b> are {{generated}} in MLR, the cellular signals {{that lead to}} activation of <b>suppressor</b> <b>T</b> <b>cells</b> as opposed to cytotoxic <b>T</b> <b>cells</b> are unknown. The current study was undertaken to characterize interactions among <b>T</b> <b>cell</b> subsets involved in the generation of <b>suppressor</b> <b>T</b> <b>cells</b> in MLR. Human peripheral blood Leu- 2 + (suppressor/cytotoxic) and Leu- 3 + (helper/inducer) <b>T</b> <b>cell</b> subsets were activated with allogeneic non-T cells and then examined for their inductive effects on fresh autologous <b>T</b> <b>cells.</b> Fresh Leu- 2 + cells proliferated in response to alloantigen-primed Leu- 3 + cells and subsequently suppressed the response of fresh autologous Leu- 3 + cells to the original, but not third party, allogeneic stimulator non-T cells. Moreover, only Leu- 2 + cells that lacked the 9. 3 marker, an antigen present on the majority of <b>T</b> <b>cells</b> including precursors of cytotoxic <b>T</b> <b>cells,</b> differentiated into <b>suppressor</b> cells. The alloantigen-specific suppressive effect of Leu- 2 +, 9. 3 -cells was not mediated by cytolysis of allogeneic stimulator cells, nor could it be explained by alteration of MLR kinetics. Suppression was observed only when activated Leu- 2 + cells were added to fresh MLRs within 24 h of initiation of cultures, suggesting that these cells block an early phase of the activation of Leu- 3 + cells in MLR. These results indicate that alloantigen-primed inducer <b>T</b> <b>cells</b> can activate alloantigen- specific <b>suppressor</b> <b>T</b> <b>cells</b> {{in the absence of}} allogeneic stimulator cells...|$|R
40|$|Following {{injection}} of rat red cells, mice develop anti-red cell autoantibodies and subsequently <b>suppressor</b> <b>T</b> <b>cells</b> specific for these. Likewise, following recovery from non-lethal malaria, they develop <b>suppressor</b> <b>T</b> <b>cells</b> which suppress the anti-lymphocyte autoantibodies induced by lethal malaria parasites. Neither type of suppressor cell affected non-autoantibody {{components of the}} response, nor a response to sheep red cells. However, there was variable but significant cross-suppression of the respective autoantibody responses by both types of suppressor cell. Possible reasons for this unexpected cross-reaction are discussed...|$|R
